The role of ozonized oil and a combination of tobramycin/dexamethasone eye drops in the treatment of viral conjunctivitis: a randomized clinical trial | Zendy

Carlo Cagini | Zendy; Marco Mariniello | Zendy; Marco Messina | Zendy; Alessio Muzi | Zendy; Maria Michiara | Zendy; A. Moretti | Zendy; Lucia Levorato | Zendy; Antonella Mencacci | Zendy

Open Access

The role of ozonized oil and a combination of tobramycin/dexamethasone eye drops in the treatment of viral conjunctivitis: a randomized clinical trial

Author(s) -

Carlo Cagini,

Marco Mariniello,

Marco Messina,

Alessio Muzi,

Maria Michiara,

A. Moretti,

Lucia Levorato,

Antonella Mencacci

Publication year - 2020

Publication title -

international ophthalmology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.716

H-Index - 45

eISSN - 1573-2630

pISSN - 0165-5701

DOI - 10.1007/s10792-020-01503-4

Subject(s) - medicine , dexamethasone , tobramycin , chemosis , keratitis , eye drop , randomized controlled trial , clinical trial , surgery , ophthalmology , antibiotics , gentamicin , microbiology and biotechnology , biology

To determine whether topical tobramycin 0.3%/dexamethasone 0.1% plus ozonized oil eye drops reduces clinical signs and infectious viral titers of presumed viral conjunctivitis more than tobramycin/dexamethasone eye drops alone.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research